Clinical and economic impact of five-year adherence to disease-modifying therapies in a commercially insured multiple sclerosis population. Bunz TJ, Xu C, Regine ML, Couto JE Value Health. 2013 May; 16(3):A109. Epub 2013 May 03. PMID: 23693219. Abstract CommentRecommendBookmarkWatch